Global Heartworm Treatment Products Market

Heartworm Treatment Products Comprehensive Study by Type (Chewable (Fluralaner, Valerian, Chamomile), Spot on (Methoprene, Fipronil, Moxidectin)), Application (Dog, Cats, Others), Distribution Channel (Veterinary Hospitals, Pharmacies & Drug stores, Veterinary Clinics) Players and Region - Global Market Outlook to 2026

Heartworm Treatment Products Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
In dogs and cats, heartworm disease is a severe medical condition. Lung disease, serious heart failure, and damage to other organs are all symptoms of heartworm infection. Heartworm infection can cause a variety of health issues as well as premature death. As a result, heartworm prevention is critical and must not be overlooked. Heartworm disease is spread by mosquitoes carrying infective heartworm larvae. Heartworm disease is most often present in dogs and cats, but it can also be found in other species such as wolves, coyotes, foxes, sea lions, and others.Adult heartworms live in the right side of the heart and the deep blood vessels that link the heart and lungs. Due to their near proximity to populated areas, foxes and coyotes are considered the primary carriers of heartworm disease. Heartworms are thought to be a natural host for dogs. Heartworm treatment for dogs normally consists of three injections: doxycycline, melarsomine, and prednisone.This growth is primarily driven by Growing Demand for Animal Welfare and Growing Adoption of Dogs.

Globally, a noticeable market trend is evident Increased Awareness about Pet’s Health. Major Players, such as Boehringer IngelheimAnimal Health (France), WELLMARK INTERNATIONAL (France), Merck Animal Health (Merck & Co., Inc.) (United States), Pfizer Inc. (United States), Bayer AG (Germany), Mylan N.V. (United States), Zoetis Inc (United States), CevaSanteAnimale S.A. (France), PetCareRx (United States) and Eli Lilly and Company (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division.

Regulatory Insights:
Many products are FDA-approved to prevent heartworms in dogs. All require a veterinarian’s prescription. Most products are given monthly, either as a topical liquid applied on the skin or as an oral table

Market Drivers
  • Growing Demand for Animal Welfare
  • Growing Adoption of Dogs

Market Trend
  • Increased Awareness about Pet’s Health

Restraints
  • Adverse Reaction of Some Drugs

Opportunities
Increased Investment in R&D of Animal Health and Growing Number of Vets in Developing Countries
Challenges
Manufactures Have to comply with the Drug Regulations

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Heartworm Treatment Products Study Sheds Light on
— The Heartworm Treatment Products Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Heartworm Treatment Products industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Heartworm Treatment Products industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Chewable (Fluralaner, Valerian, Chamomile)
  • Spot on (Methoprene, Fipronil, Moxidectin)
By Application
  • Dog
  • Cats
  • Others
By Distribution Channel
  • Veterinary Hospitals
  • Pharmacies & Drug stores
  • Veterinary Clinics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand for Animal Welfare
      • 3.2.2. Growing Adoption of Dogs
    • 3.3. Market Challenges
      • 3.3.1. Manufactures Have to comply with the Drug Regulations
    • 3.4. Market Trends
      • 3.4.1. Increased Awareness about Pet’s Health
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Heartworm Treatment Products, by Type, Application, Distribution Channel and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Heartworm Treatment Products (Value)
      • 5.2.1. Global Heartworm Treatment Products by: Type (Value)
        • 5.2.1.1. Chewable (Fluralaner, Valerian, Chamomile)
        • 5.2.1.2. Spot on (Methoprene, Fipronil, Moxidectin)
      • 5.2.2. Global Heartworm Treatment Products by: Application (Value)
        • 5.2.2.1. Dog
        • 5.2.2.2. Cats
        • 5.2.2.3. Others
      • 5.2.3. Global Heartworm Treatment Products by: Distribution Channel (Value)
        • 5.2.3.1. Veterinary Hospitals
        • 5.2.3.2. Pharmacies & Drug stores
        • 5.2.3.3. Veterinary Clinics
      • 5.2.4. Global Heartworm Treatment Products Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Heartworm Treatment Products: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boehringer IngelheimAnimal Health (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. WELLMARK INTERNATIONAL (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck Animal Health (Merck & Co., Inc.) (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bayer AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Mylan N.V. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Zoetis Inc (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. CevaSanteAnimale S.A. (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. PetCareRx (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Eli Lilly and Company (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Heartworm Treatment Products Sale, by Type, Application, Distribution Channel and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Heartworm Treatment Products (Value)
      • 7.2.1. Global Heartworm Treatment Products by: Type (Value)
        • 7.2.1.1. Chewable (Fluralaner, Valerian, Chamomile)
        • 7.2.1.2. Spot on (Methoprene, Fipronil, Moxidectin)
      • 7.2.2. Global Heartworm Treatment Products by: Application (Value)
        • 7.2.2.1. Dog
        • 7.2.2.2. Cats
        • 7.2.2.3. Others
      • 7.2.3. Global Heartworm Treatment Products by: Distribution Channel (Value)
        • 7.2.3.1. Veterinary Hospitals
        • 7.2.3.2. Pharmacies & Drug stores
        • 7.2.3.3. Veterinary Clinics
      • 7.2.4. Global Heartworm Treatment Products Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Heartworm Treatment Products: by Type(USD Million)
  • Table 2. Heartworm Treatment Products Chewable (Fluralaner, Valerian, Chamomile) , by Region USD Million (2015-2020)
  • Table 3. Heartworm Treatment Products Spot on (Methoprene, Fipronil, Moxidectin) , by Region USD Million (2015-2020)
  • Table 4. Heartworm Treatment Products: by Application(USD Million)
  • Table 5. Heartworm Treatment Products Dog , by Region USD Million (2015-2020)
  • Table 6. Heartworm Treatment Products Cats , by Region USD Million (2015-2020)
  • Table 7. Heartworm Treatment Products Others , by Region USD Million (2015-2020)
  • Table 8. Heartworm Treatment Products: by Distribution Channel(USD Million)
  • Table 9. Heartworm Treatment Products Veterinary Hospitals , by Region USD Million (2015-2020)
  • Table 10. Heartworm Treatment Products Pharmacies & Drug stores , by Region USD Million (2015-2020)
  • Table 11. Heartworm Treatment Products Veterinary Clinics , by Region USD Million (2015-2020)
  • Table 12. South America Heartworm Treatment Products, by Country USD Million (2015-2020)
  • Table 13. South America Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 14. South America Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 15. South America Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 16. Brazil Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 17. Brazil Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 18. Brazil Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 19. Argentina Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 20. Argentina Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 21. Argentina Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 22. Rest of South America Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 23. Rest of South America Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 24. Rest of South America Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 25. Asia Pacific Heartworm Treatment Products, by Country USD Million (2015-2020)
  • Table 26. Asia Pacific Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 27. Asia Pacific Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 28. Asia Pacific Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 29. China Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 30. China Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 31. China Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 32. Japan Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 33. Japan Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 34. Japan Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 35. India Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 36. India Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 37. India Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 38. South Korea Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 39. South Korea Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 40. South Korea Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 41. Taiwan Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 42. Taiwan Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 43. Taiwan Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 44. Australia Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 45. Australia Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 46. Australia Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 50. Europe Heartworm Treatment Products, by Country USD Million (2015-2020)
  • Table 51. Europe Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 52. Europe Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 53. Europe Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 54. Germany Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 55. Germany Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 56. Germany Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 57. France Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 58. France Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 59. France Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 60. Italy Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 61. Italy Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 62. Italy Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 63. United Kingdom Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 64. United Kingdom Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 65. United Kingdom Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 66. Netherlands Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 67. Netherlands Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 68. Netherlands Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 69. Rest of Europe Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 70. Rest of Europe Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 71. Rest of Europe Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 72. MEA Heartworm Treatment Products, by Country USD Million (2015-2020)
  • Table 73. MEA Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 74. MEA Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 75. MEA Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 76. Middle East Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 77. Middle East Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 78. Middle East Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 79. Africa Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 80. Africa Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 81. Africa Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 82. North America Heartworm Treatment Products, by Country USD Million (2015-2020)
  • Table 83. North America Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 84. North America Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 85. North America Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 86. United States Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 87. United States Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 88. United States Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 89. Canada Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 90. Canada Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 91. Canada Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 92. Mexico Heartworm Treatment Products, by Type USD Million (2015-2020)
  • Table 93. Mexico Heartworm Treatment Products, by Application USD Million (2015-2020)
  • Table 94. Mexico Heartworm Treatment Products, by Distribution Channel USD Million (2015-2020)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Heartworm Treatment Products: by Type(USD Million)
  • Table 106. Heartworm Treatment Products Chewable (Fluralaner, Valerian, Chamomile) , by Region USD Million (2021-2026)
  • Table 107. Heartworm Treatment Products Spot on (Methoprene, Fipronil, Moxidectin) , by Region USD Million (2021-2026)
  • Table 108. Heartworm Treatment Products: by Application(USD Million)
  • Table 109. Heartworm Treatment Products Dog , by Region USD Million (2021-2026)
  • Table 110. Heartworm Treatment Products Cats , by Region USD Million (2021-2026)
  • Table 111. Heartworm Treatment Products Others , by Region USD Million (2021-2026)
  • Table 112. Heartworm Treatment Products: by Distribution Channel(USD Million)
  • Table 113. Heartworm Treatment Products Veterinary Hospitals , by Region USD Million (2021-2026)
  • Table 114. Heartworm Treatment Products Pharmacies & Drug stores , by Region USD Million (2021-2026)
  • Table 115. Heartworm Treatment Products Veterinary Clinics , by Region USD Million (2021-2026)
  • Table 116. South America Heartworm Treatment Products, by Country USD Million (2021-2026)
  • Table 117. South America Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 118. South America Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 119. South America Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 120. Brazil Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 121. Brazil Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 122. Brazil Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 123. Argentina Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 124. Argentina Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 125. Argentina Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 126. Rest of South America Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 127. Rest of South America Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 128. Rest of South America Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 129. Asia Pacific Heartworm Treatment Products, by Country USD Million (2021-2026)
  • Table 130. Asia Pacific Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 131. Asia Pacific Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 132. Asia Pacific Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 133. China Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 134. China Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 135. China Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 136. Japan Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 137. Japan Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 138. Japan Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 139. India Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 140. India Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 141. India Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 142. South Korea Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 143. South Korea Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 144. South Korea Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 145. Taiwan Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 146. Taiwan Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 147. Taiwan Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 148. Australia Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 149. Australia Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 150. Australia Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 151. Rest of Asia-Pacific Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 152. Rest of Asia-Pacific Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 153. Rest of Asia-Pacific Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 154. Europe Heartworm Treatment Products, by Country USD Million (2021-2026)
  • Table 155. Europe Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 156. Europe Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 157. Europe Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 158. Germany Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 159. Germany Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 160. Germany Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 161. France Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 162. France Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 163. France Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 164. Italy Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 165. Italy Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 166. Italy Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 167. United Kingdom Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 168. United Kingdom Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 169. United Kingdom Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 170. Netherlands Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 171. Netherlands Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 172. Netherlands Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 173. Rest of Europe Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 174. Rest of Europe Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 175. Rest of Europe Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 176. MEA Heartworm Treatment Products, by Country USD Million (2021-2026)
  • Table 177. MEA Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 178. MEA Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 179. MEA Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 180. Middle East Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 181. Middle East Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 182. Middle East Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 183. Africa Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 184. Africa Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 185. Africa Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 186. North America Heartworm Treatment Products, by Country USD Million (2021-2026)
  • Table 187. North America Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 188. North America Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 189. North America Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 190. United States Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 191. United States Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 192. United States Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 193. Canada Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 194. Canada Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 195. Canada Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 196. Mexico Heartworm Treatment Products, by Type USD Million (2021-2026)
  • Table 197. Mexico Heartworm Treatment Products, by Application USD Million (2021-2026)
  • Table 198. Mexico Heartworm Treatment Products, by Distribution Channel USD Million (2021-2026)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Heartworm Treatment Products: by Type USD Million (2015-2020)
  • Figure 5. Global Heartworm Treatment Products: by Application USD Million (2015-2020)
  • Figure 6. Global Heartworm Treatment Products: by Distribution Channel USD Million (2015-2020)
  • Figure 7. South America Heartworm Treatment Products Share (%), by Country
  • Figure 8. Asia Pacific Heartworm Treatment Products Share (%), by Country
  • Figure 9. Europe Heartworm Treatment Products Share (%), by Country
  • Figure 10. MEA Heartworm Treatment Products Share (%), by Country
  • Figure 11. North America Heartworm Treatment Products Share (%), by Country
  • Figure 12. Global Heartworm Treatment Products share by Players 2020 (%)
  • Figure 13. Global Heartworm Treatment Products share by Players (Top 3) 2020(%)
  • Figure 14. Global Heartworm Treatment Products share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Boehringer IngelheimAnimal Health (France) Revenue, Net Income and Gross profit
  • Figure 17. Boehringer IngelheimAnimal Health (France) Revenue: by Geography 2020
  • Figure 18. WELLMARK INTERNATIONAL (France) Revenue, Net Income and Gross profit
  • Figure 19. WELLMARK INTERNATIONAL (France) Revenue: by Geography 2020
  • Figure 20. Merck Animal Health (Merck & Co., Inc.) (United States) Revenue, Net Income and Gross profit
  • Figure 21. Merck Animal Health (Merck & Co., Inc.) (United States) Revenue: by Geography 2020
  • Figure 22. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 24. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 25. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 26. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Mylan N.V. (United States) Revenue: by Geography 2020
  • Figure 28. Zoetis Inc (United States) Revenue, Net Income and Gross profit
  • Figure 29. Zoetis Inc (United States) Revenue: by Geography 2020
  • Figure 30. CevaSanteAnimale S.A. (France) Revenue, Net Income and Gross profit
  • Figure 31. CevaSanteAnimale S.A. (France) Revenue: by Geography 2020
  • Figure 32. PetCareRx (United States) Revenue, Net Income and Gross profit
  • Figure 33. PetCareRx (United States) Revenue: by Geography 2020
  • Figure 34. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 35. Eli Lilly and Company (United States) Revenue: by Geography 2020
  • Figure 36. Global Heartworm Treatment Products: by Type USD Million (2021-2026)
  • Figure 37. Global Heartworm Treatment Products: by Application USD Million (2021-2026)
  • Figure 38. Global Heartworm Treatment Products: by Distribution Channel USD Million (2021-2026)
  • Figure 39. South America Heartworm Treatment Products Share (%), by Country
  • Figure 40. Asia Pacific Heartworm Treatment Products Share (%), by Country
  • Figure 41. Europe Heartworm Treatment Products Share (%), by Country
  • Figure 42. MEA Heartworm Treatment Products Share (%), by Country
  • Figure 43. North America Heartworm Treatment Products Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Boehringer IngelheimAnimal Health (France)
  • WELLMARK INTERNATIONAL (France)
  • Merck Animal Health (Merck & Co., Inc.) (United States)
  • Pfizer Inc. (United States)
  • Bayer AG (Germany)
  • Mylan N.V. (United States)
  • Zoetis Inc (United States)
  • CevaSanteAnimale S.A. (France)
  • PetCareRx (United States)
  • Eli Lilly and Company (United States)
Additional players considered in the study are as follows:
Alivira Animal Health Ltd. (India) , HEARTGARD Plus (United States) , Zovix Pharmaceuticals (India) , AdvaCare Pharma (India)
Select User Access Type

Key Highlights of Report


Apr 2021 250 Pages 59 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Heartworm Treatment Products Market Quantitative research analysis
Global Heartworm Treatment Products Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Heartworm Treatment Products Market Report?

Have a Query? Click Here

Other Related Reports

Constipation Laxative Comprehensive Study by Type (Bulk-forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softener Laxatives, Others (Lubricant laxatives, Saline laxatives, and Prokine...
$ 3750
Tribulus Terrestris Extract Comprehensive Study by Nature (Organic, Conventional), Form (Powder, Liquid Capsules, Liquid Syrup, Tinctures), End Use (Pharmaceuticals, Dietary Supplement, Others) Playe...
$ 3500
Etanercept Drugs Comprehensive Study by Application (Arthritis, Psoriasis, Spondylitis), Distribution Channel (Online, Offline) Players and Region - Global Market Outlook to 2026
$ 3500
Period Cramp Pain Killer Comprehensive Study by Type (Ibuprofen, Ketoprofen, Naproxen), Application (Endometriosis, Uterine Fibroids, Adenomyosis, Pelvic Inflammatory Disease, Cervical Stenosis), Mod...
$ 3750
DTaP Vaccine  Comprehensive Study by Type (Diphtheria, Tetanus, Pertussis), Application (Adult, Pediatric), Product Type (Generic Drug, Branded Drug), End User (Hospitals, Clinics, Vaccination Center...
$ 3500
Eszopiclone Comprehensive Study by Type (Eszopiclone 1mg Tablet, Eszopiclone 2mg Tablet, Eszopiclone 3mg Tablet), End-users (Hospitals, Clinics, Others), Distribution Channel (Hospital Pharmacies, Re...
$ 3350